CN104306458B - A preparation for treating visceral white-spot disease of pseudosciaena crocea and uses thereof - Google Patents

A preparation for treating visceral white-spot disease of pseudosciaena crocea and uses thereof Download PDF

Info

Publication number
CN104306458B
CN104306458B CN201410501361.4A CN201410501361A CN104306458B CN 104306458 B CN104306458 B CN 104306458B CN 201410501361 A CN201410501361 A CN 201410501361A CN 104306458 B CN104306458 B CN 104306458B
Authority
CN
China
Prior art keywords
parts
vitamin
extract
preparation
herba cistanches
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201410501361.4A
Other languages
Chinese (zh)
Other versions
CN104306458A (en
Inventor
薛锐勇
徐向飞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhejiang Ocean University ZJOU
Original Assignee
Zhejiang Ocean University ZJOU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhejiang Ocean University ZJOU filed Critical Zhejiang Ocean University ZJOU
Priority to CN201410501361.4A priority Critical patent/CN104306458B/en
Publication of CN104306458A publication Critical patent/CN104306458A/en
Application granted granted Critical
Publication of CN104306458B publication Critical patent/CN104306458B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07Retinol compounds, e.g. vitamin A
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/375Ascorbic acid, i.e. vitamin C; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/65Tetracyclines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/64Orobanchaceae (Broom-rape family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10Preparation or pretreatment of starting material
    • A61K2236/15Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10Preparation or pretreatment of starting material
    • A61K2236/17Preparation or pretreatment of starting material involving drying, e.g. sun-drying or wilting
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/39Complex extraction schemes, e.g. fractionation or repeated extraction steps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/51Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a preparation for treating visceral white-spot disease of pseudosciaena crocea and uses thereof, and belongs to the technical field of fishery. The preparation and the uses thereof are characterized in that: the preparation comprises 30-40 parts of a compound cyme extract product, 20-30 parts of a cistanche deserticola extract product, 10-15 parts of doxycycline, 4-6 parts of vitamin A, 2-5 parts of vitamin E and 6-10 parts of vitamin C. According to the preparation and the uses thereof, treating effects of the preparation for the visceral white-spot disease of the pseudosciaena crocea are good, components are compatible and synergistic, and the preparation has immunity-boosting and antimutation effects, reduces drug resistance of the pseudosciaena crocea, increases the rate of survival of the pseudosciaena crocea, accelerates the growth speed, and improves quality of fish.

Description

A kind of preparation for treating Radix Et Rhizoma Rhei fish internal organs ichthyophthiriasises and application thereof
Technical field
The invention belongs to technical field of fishery, specially a kind of preparation for treating Radix Et Rhizoma Rhei fish internal organs ichthyophthiriasises and application thereof.
Background technology
Carnis Pseudosciaenae, is one of traditional four big marine products, China coastal seas Main Commercial Fishes, containing rich in protein, micro Element, vitamin and trace element-selenium, to have a delicate constitution and middle-aged and elderly people for, edible Channa argus can receive good dietetic therapy effect Really, the free radical of body metabolism generation can be removed, can slow down aging.Radix Et Rhizoma Rhei fish internal organs ichthyophthiriasises Symptoms are:The ill initial stage Sick fish body table non-evident sympton, only bradykinesia, loss of appetite, peel off upper floatation surface then, solely swims or be still in net cage bottom, Body constitution does not almost see symptom, but increasing with the state of an illness compared with weak person's i.e. death soon, body surface, and part fish body table occurs in that white Or faint yellow speckle;Body surface has damage and ulcer, and bleeding is rubescent, and tail fin and chin also have bleeding, rubescent, and subsequent mortality is gradually Increase.Under the conditions of Fish intensive culture, the Fish of cultivation easily receive such environmental effects, and fish medicine is easy to produce drug resistance Property, so as to cause Carnis Pseudosciaenae survival rate relatively low, the speed of growth is slower, the quality decline of the flesh of fish.
The content of the invention
For the problems referred to above of presence of the prior art, the present invention's is that design offer one kind treats Radix Et Rhizoma Rhei fish internal organs The technical scheme of the preparation of ichthyophthiriasises and application thereof, its therapeutic effect to Radix Et Rhizoma Rhei fish internal organs ichthyophthiriasises is good, and mutual compatibility is not only With synergistic function, the Drug resistance of Carnis Pseudosciaenae is also reduced, improve Carnis Pseudosciaenae survival rate, accelerate the speed of growth, improved Flesh quality.
Described a kind of preparation for treating Radix Et Rhizoma Rhei fish internal organs ichthyophthiriasises, it is characterised in that containing compound cyme extract 30-40 parts, Herba Cistanches extract 20-30 parts, doxycycline 10-15 parts, vitamin A 4-6 parts, -5 parts of vitamin E2, vitamin C6-10 parts;Described compound cyme extract is prepared using following methods:Compound cyme is dried, crushes, and 5-8 times is measured water Ebuillition of heated is extracted 2-3 time, each 1-2 hours, and united extraction liquid is concentrated in vacuo, be drying to obtain compound cyme extract powder End;Described Herba Cistanches extract is prepared using following methods:Herba Cistanches are dried, crush, and measure water ebuillition of heated for 5-8 times and extract 2- 3 times, each 1-2 hours, united extraction liquid is concentrated in vacuo, be drying to obtain Herba Cistanches extract powder.
A kind of described preparation for treating Radix Et Rhizoma Rhei fish internal organs ichthyophthiriasises, it is characterised in that 30 parts of compound cyme extract, 20 parts of Herba Cistanches extract, 10 parts of doxycycline, 4 parts of vitamin A, vitamin E2 part, 6 parts of vitamin C.
A kind of described preparation for treating Radix Et Rhizoma Rhei fish internal organs ichthyophthiriasises, it is characterised in that 40 parts of compound cyme extract, 30 parts of Herba Cistanches extract, 12 parts of doxycycline, 6 parts of vitamin A, 5 parts of Vitamin E, 10 parts of vitamin C.
A kind of described preparation for treating Radix Et Rhizoma Rhei fish internal organs ichthyophthiriasises, it is characterised in that 35 parts of compound cyme extract, 25 parts of Herba Cistanches extract, 15 parts of doxycycline, 5 parts of vitamin A, 4 parts of Vitamin E, 8 parts of vitamin C.
Application of the described compound cyme in the preparation for preparing treatment Radix Et Rhizoma Rhei fish internal organs ichthyophthiriasises.
Application of the described Herba Cistanches in the preparation for preparing treatment Radix Et Rhizoma Rhei fish internal organs ichthyophthiriasises.
Compound cyme, perennial herb, high 50~100cm;Main root is cylindric, skin near-white;Stem four ribs of summary, many points Branch, dredges growth rough hair;Leaf opposite, petiole 5~15mm of length;Blade is oval or narrow ellipse, minority obovate, long 3~12cm, Wide 1.5~5.5m, tip is tapering or tail point, base portion wedge shape or wide wedge shape, full edge, above adhesion long bristles, below hair it is closeer;It is multiple Cyme is intensive into bouquet group.Excavate when winter stem and leaf is withered, remove fibrous root and silt, be bundled into wisp, shine to shriveling, will Top trims, and dries.Containing containing effective ingredient such as steroid, amino acidses, saponin, polysaccharide, alkaloids in its extract, have very Strong immunoregulation effect.
Cistanche deserticola Orobanchaceae endangered species, call big rue, very little rue, Herba Cistanchess, and main product is in the Alashan League of Inner Mongolia Autonomous Region And Xinjiang, Herba Cistanches are a kind of parasitic plants for colonizing in desert trees sacsaoul root, and nutrient and water are drawn from sacsaoul host Part.Herba Cistanches extract has very strong antibacterial, antiinflammatory and adjusts body's immunity.
Above-mentioned a kind of preparation for treating Radix Et Rhizoma Rhei fish internal organs ichthyophthiriasises and application thereof, its treatment to Radix Et Rhizoma Rhei fish internal organs ichthyophthiriasises Effect is good, and mutual compatibility not only has synergistic function, with enhancing immunity, antimutagenicity, also reduces Carnis Pseudosciaenae Drug resistance, improves Carnis Pseudosciaenae survival rate, accelerates the speed of growth, improves flesh quality.
The percentage composition being related in present specification is unless otherwise indicated, other to be weight percentage.
Specific embodiment
Below by way of specific embodiment, the invention will be further described, and further illustrates the present invention with reference to the test of pesticide effectiveness Beneficial effect.
Embodiment 1
30 parts of compound cyme extract, 20 parts of Herba Cistanches extract, 10 parts of doxycycline, 4 parts of vitamin A, vitamin 6 parts of E2 parts, vitamin C;Described compound cyme extract is prepared using following methods:Compound cyme is dried, crushes, 5- 8 times of amount water ebuillition of heated are extracted 2-3 time, each 1-2 hours, united extraction liquid, concentrated in vacuo, be drying to obtain compound cyme and carry Take thing powder;Described Herba Cistanches extract is prepared using following methods:Herba Cistanches are dried, crush, and 5-8 times is measured water ebuillition of heated Extract 2-3 time, each 1-2 hours, united extraction liquid is concentrated in vacuo, be drying to obtain Herba Cistanches extract powder.
The step of above-described embodiment 11)40 parts of middle compound cyme extract, 30 parts of Herba Cistanches extract, doxycycline 12 Part, 6 parts of vitamin A, 5 parts of Vitamin E, 10 parts of vitamin C;Or 35 parts of compound cyme extract, 25 parts of Herba Cistanches extract, 15 parts of doxycycline, 5 parts of vitamin A, 4 parts of Vitamin E, 8 parts of vitamin C, other all embodiments 1 can also obtain the present invention's Technique effect.
It is according to the ratio that 1 gram is admixed per 100 grams of feedstuffs that above-mentioned preparation is direct with fish meal.
Beneficial effects of the present invention are further illustrated below in conjunction with contrast test.
Test 1:
4 groups of Carnis Pseudosciaenae with internal organs ichthyophthiriasises are selected, 10 per group, embodiment 1 is respectively adopted to be carried out according to amount of application Process, matched group 1 is admixed for doxycycline and fed in Radix Et Rhizoma Rhei fish meal, and matched group 2 admixes Radix Et Rhizoma Rhei for compound cyme extract Feed in fish meal, matched group 3 is admixed for Herba Cistanches extract and fed in Radix Et Rhizoma Rhei fish meal, in matched group 1-3, matched group 1-3 Middle doxycycline, compound cyme extract, the content of Herba Cistanches extract feed daily 1 time with embodiment 1, even feed 5 days. Result of the test is shown in Table 1.
The therapeutic effect table of 1 embodiment of table, 1 pair of Carnis Pseudosciaenae with internal organs ichthyophthiriasises
Process Ill Carnis Pseudosciaenae number It is effective Effectively It is invalid Total effective rate(%)
Embodiment 1 10 9 1 0 100
Matched group 1 10 3 3 4 60
Matched group 2 10 2 5 3 70
Matched group 3 10 3 5 2 80
Result of the test shows:Embodiment 1-4 has good curative effect to Radix Et Rhizoma Rhei fish internal organs ichthyophthiriasises, is above matched group 1-3, It can thus be seen that very aobvious to the therapeutic effect of Radix Et Rhizoma Rhei fish internal organs ichthyophthiriasises using fish medicine obtained in complex preparation of the present invention Write, each component has significant cooperative synergism effect.

Claims (4)

1. a kind of preparation for treating Radix Et Rhizoma Rhei fish internal organs ichthyophthiriasises, it is characterised in that containing Radix Cyathulae extract 30-40 parts, Herba Cistanches Extract 20-30 parts, doxycycline 10-15 parts, vitamin A 4-6 parts, -5 parts of vitamin E2, vitamin C 6-10 parts;Described Radix Cyathulae extract is prepared using following methods:Radix Cyathulae is dried, crushes, and 5-8 times is measured water ebuillition of heated extraction 2-3 time, every time 1-2 hours, united extraction liquid is concentrated in vacuo, be drying to obtain Radix Cyathulae extract powder;Described Herba Cistanches extract adopt with It is prepared by lower section method:Herba Cistanches are dried, crush, and measure water ebuillition of heated for 5-8 times and extract 2-3 time, each 1-2 hours, united extraction liquid, It is concentrated in vacuo, be drying to obtain Herba Cistanches extract powder.
2. a kind of preparation for treating Radix Et Rhizoma Rhei fish internal organs ichthyophthiriasises as claimed in claim 1, it is characterised in that Radix Cyathulae extract 30 parts, 20 parts of Herba Cistanches extract, 10 parts of doxycycline, 4 parts of vitamin A, vitamin E2 part, 6 parts of vitamin C.
3. a kind of preparation for treating Radix Et Rhizoma Rhei fish internal organs ichthyophthiriasises as claimed in claim 1, it is characterised in that Radix Cyathulae extract 40 parts, 30 parts of Herba Cistanches extract, 12 parts of doxycycline, 6 parts of vitamin A, 5 parts of Vitamin E, 10 parts of vitamin C.
4. a kind of preparation for treating Radix Et Rhizoma Rhei fish internal organs ichthyophthiriasises as claimed in claim 1, it is characterised in that Radix Cyathulae extract 35 parts, 25 parts of Herba Cistanches extract, 15 parts of doxycycline, 5 parts of vitamin A, 4 parts of Vitamin E, 8 parts of vitamin C.
CN201410501361.4A 2014-09-26 2014-09-26 A preparation for treating visceral white-spot disease of pseudosciaena crocea and uses thereof Expired - Fee Related CN104306458B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410501361.4A CN104306458B (en) 2014-09-26 2014-09-26 A preparation for treating visceral white-spot disease of pseudosciaena crocea and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410501361.4A CN104306458B (en) 2014-09-26 2014-09-26 A preparation for treating visceral white-spot disease of pseudosciaena crocea and uses thereof

Publications (2)

Publication Number Publication Date
CN104306458A CN104306458A (en) 2015-01-28
CN104306458B true CN104306458B (en) 2017-04-26

Family

ID=52361867

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410501361.4A Expired - Fee Related CN104306458B (en) 2014-09-26 2014-09-26 A preparation for treating visceral white-spot disease of pseudosciaena crocea and uses thereof

Country Status (1)

Country Link
CN (1) CN104306458B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109316448A (en) * 2018-10-16 2019-02-12 浙江海洋大学 The medicament of cage culture prevention and treatment fresh water ich

Also Published As

Publication number Publication date
CN104306458A (en) 2015-01-28

Similar Documents

Publication Publication Date Title
Ajuru et al. A review on the economic uses of species of Cucurbitaceae and their sustainability in Nigeria
CN103039745B (en) Daily ration concentrated feed of egg-laying sheldrake and preparation method thereof
KR100908738B1 (en) A method for extracting β-glucan of Astragalus and feed composition comprising the β-glucan
KR20170046528A (en) Mixed composition to prevent hair loss and promote growing hair providing natural oriental material including artemisiae apiaceae herba, chrysanthemi zawadskii herba, artemisiae argyi herba, artemisiae capillaris herba, sophorae fructus, cirsii herba, and aucklandiae radix extracts and manufacturing method using the same
KR100939906B1 (en) Oriental medicine extract for farming fish of the same
CN105325717A (en) Porcupine feeding food and feeding method thereof
CN105029110A (en) Mixed feed for onychostoma simum and preparing method of mixed feed
KR101676603B1 (en) Natural Hair Restorer and how to make it
CN105211502A (en) Green feed additive
JPS61119144A (en) Feed for improving meat quality
KR101024429B1 (en) Composition for feed for poultry comprising oriental herb
CN104306458B (en) A preparation for treating visceral white-spot disease of pseudosciaena crocea and uses thereof
KR20130100406A (en) The maunfacturing methdod of feed using a by-product of ginseng steamed red
KR102254420B1 (en) Antimicrobial composition comprising the fermentation extract of medicinal or edible natural products
CN104381648A (en) Chicken feed additive and preparation method thereof
CN104322918A (en) Medical feed capable of preventing diseases of golden pompanos
CN106509412A (en) Cattle feed containing Chinese herbs, and preparation method thereof
CN106343271A (en) Turtle fodder
CN105053737A (en) High-efficiency pig feed additive
KR20100065977A (en) Functional assorted feed comprising seabuckthorn
CN107594175A (en) A kind of organic pig feed of growth promotion and preparation method thereof
CN107568491A (en) A kind of chicken feed for adding medicinal material and preparation method thereof
CN103751313B (en) A kind of prevention and the Chinese herbal compound preparation for the treatment of fish disease
CN105211528A (en) One boar green feed additive
CN105146058A (en) Feed additive product

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20170426

Termination date: 20180926

CF01 Termination of patent right due to non-payment of annual fee